Zydus Lifesciences acquires 6.5% stake in Mylab Discovery Solutions

18 Sep 2023 Evaluate

Zydus Lifesciences has completed the acquisition of 65,06,500 equity shares of Re 1 each representing 6.5% of the total paid-up share capital of Mylab Discovery Solutions on September 18, 2023. The said acquisition in Mylab will help the company to participate in growing diagnostics space which is expected to witness increased penetration through in-clinic solutions with Point of Care Testing (POCT) devices.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×